Gilead Stock News

Unison Advisors LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 19.8% during the 3rd quarter, Holdings Channel.com reports. The firm owned 20,535 shares of the biopharmaceutical companys stock after selling 5,055 shares during the period. Unison Advisors LLCs holdings in Gilead Sciences were worth $1,435,000 at the end of the most []

Gilead Sciences has stagnated over the last 5 years while spending significant capital to try to build a new business.

Two big biotechs and one smaller one that could be winners over the long term.

Pflug Koory LLC decreased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 15.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,695 shares of the biopharmaceutical companys stock after selling 500 shares during the quarter. Pflug Koory LLCs holdings in Gilead Sciences []

Gilead Sciences, Inc. (GILD) Management Presents at 4th Annual Evercore ISI HealthCONx Virtual Conference (Transcript)

Seelaus Asset Management LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ:GILD) by 4.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,110 shares of the biopharmaceutical companys stock after buying an additional 425 shares during the quarter. Seelaus Asset Management LLCs []

Stratos Wealth Partners LTD. decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD) by 3.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,723 shares of the biopharmaceutical company’s stock after selling 3,130 shares during the period. Stratos Wealth Partners […]

Escobar: Fauci As Darth Vader Of The COVID Wars Authored by Pepe Escobar via The Asia Times, Robert F Kennedy Jrs The Real Anthony Fauci: Bill Gates, Big Pharma and the Global War on Democracy and Public Health should be front-page news in all the news media in the US. Instead, it has been met with the proverbial thundering silence. Critics seeking to have Kennedy dismissed as a kook trading on a famous name had scored a hit in February, when Instagram permanently deleted his account , allegedly for making false claims about coronavirus and vaccines. Nevertheless, the book, published only a few days ago, is already a certified pop hit on Amazon . RFK Jr., chairman of the board of and chief legal counsel for Childrens Health Defense, sets out to deconstruct a New Normal, encroaching upon all of us since early 2020. In my early 2021 book Raging Twenties I have termed this force techno-feudalism. Kennedy describes it as rising totalitarianism, complete with mass propaganda and censorship, the orchestrated promotion of terror, the manipulation of science, the suppression of debate, the vilification of dissent and use of force to prevent protest. Focusing on Dr Anthony Fauci as the fulcrum of the biggest story of the 21st century allows RFK Jr to paint a complex canvas of planned militarization and, especially, monetization of medicine, a toxic process managed by Big Pharma, Big Tech and the military/intel complex and dutifully promoted by mainstream media.

With AWS the cloud of choice, Gilead leverages AWS machine learning and analytics to better educate clinical trial design and drive data-driven decision-making while prioritizing patient privacy and safety Gilead is also transforming its enterprise resource planning workloads on AWS to implement SAP S / 4HANA in its global business The post Gilead and AWS Partner to Develop and Deliver New Drugs to Patients appeared first on iTechnology Series .

Read Article Amazon Web Services, Inc. (AWS) announced that Gilead Sciences has selected AWS as its preferred cloud provider. Innovating on AWS and with the help of AWS experts and partners in healthcare and life sciences, Gilead provides its data scientists with the latest advances in machine learning and analytics. These capabilities fuel data-driven decision [] The post Gilead partners with AWS for the development and delivery of new medicines appeared first on CRN - India .

This article was originally published on TipRanks.com Biopharmaceutical company Gilead Sciences, Inc. The post AWS Selected as Preferred Partner by Gilead Sciences appeared first on Smarter Analyst .

Amazon's (AMZN) AWS is chosen by Gilead Sciences as the preferred cloud provider.

HIV is treated with antiretroviral medicines, which work by stopping the virus replicating in the body. This allows the immune system to repair itself and prevent further damage. A combination of HIV drugs is used because HIV can quickly adapt